Skip to content

A randomized controlled study of intravenous tranexamic acid at different time points in total knee arthroplasty under tourniquet conditions

A randomized controlled study of intravenous tranexamic acid at different time points in total knee arthroplasty under tourniquet conditions

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053885
Enrollment
Unknown
Registered
2021-12-02
Start date
2022-01-01
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of knee joint

Interventions

Group A:TXA 20mg/kg+100ml normal saline was intravenously instilled 10 minutes before skin incision, and the instillation was completed 10 minutes
Group B:Inject TXA 20mg/kg+100ml saline 10 minutes before loosening the tourniquet, and finish the instillation within 10 minutes

Sponsors

Panzhihua Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for severe knee osteoarthritis of the American College of Rheumatology; 2. Patients who are ineffective after strict conservative treatment; 3. First time receiving unilateral TKA surgery; 4. The patients and their families agreed to the operation, were informed about the research and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Those who have anemia or other blood system diseases before surgery; 2. Patients with a history of severe cardiovascular disease and/or still taking oral anticoagulant drugs before surgery; 3. Patients with prior arterial occlusion, venous thrombosis or medical history of both lower extremities; 4. Those who have pre-storage autologous blood transfusion or those who require the use of blood transfusion devices; 5. Those with contraindications to the use of tranexamic acid or low molecular weight heparin; 6. Can not cooperate with the test.

Design outcomes

Primary

MeasureTime frame
Blood loss;Blood routine;Subcutaneous ecchymosis rate;Surgical limb circumference change rate;Occurrence of thrombus-related events;

Secondary

MeasureTime frame
Visual analogue scale function score;American hospital for special surgery knee score;

Countries

China

Contacts

Public ContactTao Qifeng

Panzhihua Central Hospital

1844491436@qq.com+86 150 8237 1005

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026